CoQ10

• In 2014 the Journal of the American College of Cardiology published a 2-year, 420-patient, placebo-controlled trial which found that, for patients with chronic heart failure, 100 mg CoQ10 taken 3 times daily in addition to standard therapy reduced cardiovascular symptoms and major adverse cardiovascular events.
• In 2013 the American Journal of Clinical Nutrition published a meta-analysis of select studies which found that CoQ10 may improve ejection fraction – an important measurement used to determine the amount of blood being pumped out of the heart – and reduce risk of heart attack in patients with congestive heart failure.
• In 2005 Biofactors published a double-blind, placebo-controlled trial involving 21 patients which found that 4 weeks of CoQ10 supplementation improved the heart’s efficiency in circulating blood throughout the body in patients with chronic heart failure.